Events

How to generate a Digital Europe project
JUN
Mon
16
10:00 - 11:30

This was 7 months ago

Location

Online

Programmes
Digital Europe HPC AI Continent Cybersecurity Advanced Digital Skills Deployment: Best use of technologies Semiconductors

DEP4ALL, the NCP Network for the Digital Europe Programme (DEP), organises a series of online training sessions for potential DEP applicants

The second session, "How to generate a DEP project", will focus on 

  • Project idea, concept building – How to develop a concept and a project according to the objectives, scope, outputs and evaluation aspect of a specific call
  • How to setup a team/Organise a consortium? Roles, tasks, responsibilities
  • Ways and tools of partner search, matchmaking (channels, methods - DEP NCP Network, Enterprise Europe Network, EU Funding&Tenders portal, b2match platform)

Registration for this session is open via this link.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.